Details for New Drug Application (NDA): 090227
✉ Email this page to a colleague
The generic ingredient in AMOXICILLIN AND CLAVULANATE POTASSIUM is amoxicillin; clavulanate potassium. There are forty-six drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the amoxicillin; clavulanate potassium profile page.
Summary for 090227
Tradename: | AMOXICILLIN AND CLAVULANATE POTASSIUM |
Applicant: | Sandoz |
Ingredient: | amoxicillin; clavulanate potassium |
Patents: | 0 |
Pharmacology for NDA: 090227
Mechanism of Action | beta Lactamase Inhibitors |
Suppliers and Packaging for NDA: 090227
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
AMOXICILLIN AND CLAVULANATE POTASSIUM | amoxicillin; clavulanate potassium | TABLET, EXTENDED RELEASE;ORAL | 090227 | ANDA | Sandoz Inc | 0781-1943 | 0781-1943-39 | 40 TABLET, MULTILAYER, EXTENDED RELEASE in 1 BOTTLE (0781-1943-39) |
AMOXICILLIN AND CLAVULANATE POTASSIUM | amoxicillin; clavulanate potassium | TABLET, EXTENDED RELEASE;ORAL | 090227 | ANDA | Sandoz Inc | 0781-1943 | 0781-1943-82 | 28 TABLET, MULTILAYER, EXTENDED RELEASE in 1 BOTTLE (0781-1943-82) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 1GM;EQ 62.5MG BASE | ||||
Approval Date: | Apr 21, 2010 | TE: | RLD: | No |
Complete Access Available with Subscription